Pfizer Earnings Preview: Patent Cliff Still Looming

With analyst revising estimates downward and the patent cliff looming, things don't look good for Pfizer earnings. More 

The Top 10 Dow Dividend Stocks for May

The 10 best blue-chip dividend stocks for May are laid out here. How do these Dow Jones heavyweights stack up against each other? More 

Pfizer Earnings Preview: 2 Ways to Trade PFE Stock

The rise of generic competition has seen PFE’s revenues founder in recent years, so anything Pfizer says about new drugs will be critical for the company's earnings next week. More 

Faithful AZN Shareholders Are Now Being Vindicated

As it turns out, AZN stock may actually have been worth more than Pfizer was offering a year ago More 

Hottest Healthcare Stocks Now – WX PFE ABC OMI

Healthcare stocks rose 0.2% on Wall Street today. More 

Is Pfizer (PFE) on the Retirement Buy List?

Pfizer (PFE) typically is touted as a great buy-and-hold investment, but there are plenty of reasons long-term investors should avoid PFE stock altogether. More 

IYH Is Seeing Large Inflows (JNJ, PFE, MRK)

One standout ETF is the iShares Dow Jones US Healthcare (ETF) (NYSEARCA:IYH), where we have detected an inflow of approximately $118.1 million. More